Related references
Note: Only part of the references are listed.Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Impact of the Dipeptidyl Peptidase-4 Inhibitor Vildagliptin on Glucose Tolerance and β-Cell Function and Mass in Insulin Receptor Substrate-2-Knockout Mice Fed a High-Fat Diet
Koichiro Sato et al.
ENDOCRINOLOGY (2012)
Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats
Wataru Inaba et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
Atsunori Kashiwagi et al.
JOURNAL OF DIABETES INVESTIGATION (2012)
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
Thomas Karagiannis et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: A large population-based study
Marta Baviera et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
Yutaka Seino et al.
JOURNAL OF DIABETES INVESTIGATION (2010)
Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis
Kristian B. Filion et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
G. Caleb Alexander et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Prevalence and anti hyperglycemic prescribing trends for patients with type 2 diabetes in Italy:: A 4-year retrospective study from national primary care data
Giampiero Mazzaglia et al.
PHARMACOLOGICAL RESEARCH (2008)
Trends in the prescription of antidiabetic medications in france: Evidence from primary care physicians
Kristina Secnik Royc et al.
ADVANCES IN THERAPY (2007)
The status of diabetes control and antidiabetic drug therapy in Japan - A cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1)
Masashi Kobayashi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003
CW Chiang et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2006)
Trends and influences on use of antidiabetic drugs in England, 1992-2003
T Walley et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes
FJ Cohen et al.
DIABETES CARE (2003)
Oral antihyperglycemic therapy for type 2 diabetes - Scientific review
SE Inzucchi
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Utilization of oral hypoglycemic agents in a drug-insured US population
SJ Boccuzzi et al.
DIABETES CARE (2001)
Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts
Q Qiao et al.
DIABETOLOGIA (2000)
Share Paper
